2025 Summit Session 3: Closing Remarks With Mr. Thomas A. Farrington

Expressions of gratitude highlight the contributions of presenters and participants. Significant advances in prostate cancer treatment are discussed, focusing on evolving therapies and managing the disease as a chronic condition. The need for increased awareness and participation of black patients in clinical trials is emphasized, showcasing positive outcomes. Audience feedback is collected to improve future programs, concluding with appreciation for the team and sponsors.

 

Mr. Thomas A. Farrington, President and Founder, PHEN